Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus.
about
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) functionIntensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureusAccessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycintcaA inactivation increases glycopeptide resistance in Staphylococcus aureus.In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaMorphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.Optimization of antibiotic dosing schedules in the light of increasing antibiotic resistance.Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycinModulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections.Identification of Functional Regulatory Residues of the β -Lactam Inducible Penicillin Binding Protein in Methicillin-Resistant Staphylococcus aureusOritavancin binds to isolated protoplast membranes but not intact protoplasts of Staphylococcus aureusAntimicrobial resistance among Gram-positive pathogens in Saudi Arabia.Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin.Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitalsActivity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus.Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance.High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion.
P2860
Q33883752-4CB212A7-1FC0-417B-A4EB-877333F12179Q33935282-3B370C02-17A9-447B-89B5-2DFDBBA6D8CAQ34107062-2DF0A0B7-819F-49B3-89F1-FFEB10ED5B4BQ34141289-07D61193-B515-4AED-8A67-EFD1852655C2Q34721614-2BEDB89D-EC33-4BC3-AD78-2996433B269DQ34783668-04D1D511-CFFB-4A79-8DCB-CBA4BD8FE920Q34823746-5CD7734E-184C-4698-B093-10104B61D919Q35023285-9426173A-A3FA-4B8E-B9EB-F94475D0B69AQ35806369-BDA85534-0A3A-44AC-B1AC-91E0ACC99A49Q35917371-9DED37CD-3415-4D26-8BBA-EC728CA73D52Q36452459-25AC94A9-624D-4A1A-B0FD-888EC19DBA74Q36670735-986386E7-E658-42A9-8F16-45832E1141F8Q36847287-1CDBC789-3C2C-42B9-8D88-D26EE1E4F838Q37101179-18531C2D-996F-420C-ACF0-C76DF3E5ABC8Q37355272-D3829665-A9B2-48C6-89CF-E935CC6AE7F9Q38023661-D00F2424-5D6B-4B6E-9AEA-3F6E082C353EQ39731937-FE275E85-0B4D-4B2F-A9DF-28E2584BFA9DQ39733372-9810EC15-3316-4F29-BA17-999C1F3256DCQ41005454-F174DBA4-9514-4E39-98A5-08A11A68BA01Q41016957-DDAE92CD-0040-47DA-88EF-BD0725CD5DE7Q42042890-72B5E263-1B2B-4D6E-B625-1EF31BE2D631Q42121862-A491ACDB-DFF0-4719-BF55-6D033A7120D7Q44596502-9519E3DF-1BE4-44BF-8ABC-F349033D96C0Q44991015-9609ACFE-8E65-4238-9AC7-5AF6AE47B458
P2860
Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@ast
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@en
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@nl
type
label
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@ast
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@en
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@nl
prefLabel
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@ast
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@en
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@nl
P2093
P356
P1476
Emergence, mechanism, and clin ...... lity in Staphylococcus aureus.
@en
P2093
Labischinski H
Schmitz FJ
P2888
P304
P356
10.1007/S100960100595
P577
2001-10-01T00:00:00Z
P6179
1051287652